ABOUT THIS EPISODE
What’s really happening in biotech right now, and where should innovators and investors be paying attention?
In this market update episode, host Elaine Hamm, PhD, is joined by guest host Travis Manasco, MD, for a candid conversation on the current state of biotech investing. Together, they unpack where momentum is building, where enthusiasm is cooling, and how founders, scientists, and investors should think strategically as the market finds its footing. From GLP-1s and AI to women’s health and preclinical challenges, this episode offers a clear-eyed look at today’s biotech landscape—just in time for JPM.
In this episode, you’ll learn:
Tune in for an honest, insightful market conversation that cuts through the hype and helps you think more clearly about where biotech is headed next.
Links:
Connect with Travis Manasco, MD, and check out Solas BioVentures.
Connect with Elaine Hamm, PhD, and learn about Tulane Medicine Business Development and the School of Medicine.
Check out the JP Morgan Healthcare Conference 2026.
Check out our previous episode with Travis on AI in Medicine.
Connect with Ian McLachlan, BIO from the BAYOU producer.
Learn more about BIO from the BAYOU - the podcast.
Bio from the Bayou is a podcast that explores biotech innovation, business development, and healthcare outcomes in New Orleans & The Gulf South, connecting biotech companies, investors, and key opinion leaders to advance medicine, technology, and startup opportunities in the region.
In this market update episode, host Elaine Hamm, PhD, is joined by guest host Travis Manasco, MD, for a candid conversation on the current state of biotech investing. Together, they unpack where momentum is building, where enthusiasm is cooling, and how founders, scientists, and investors should think strategically as the market finds its footing. From GLP-1s and AI to women’s health and preclinical challenges, this episode offers a clear-eyed look at today’s biotech landscape—just in time for JPM.
In this episode, you’ll learn:
- Which biotech sectors are heating up and why areas like obesity, AI-enabled clinical trials, and women’s health are drawing renewed interest
- Why early-stage and preclinical innovation remains a tough funding environment, despite long-term opportunity
- How market signals like acquisitions and JPM dynamics may shape biotech strategy in the year ahead
Tune in for an honest, insightful market conversation that cuts through the hype and helps you think more clearly about where biotech is headed next.
Links:
Connect with Travis Manasco, MD, and check out Solas BioVentures.
Connect with Elaine Hamm, PhD, and learn about Tulane Medicine Business Development and the School of Medicine.
Check out the JP Morgan Healthcare Conference 2026.
Check out our previous episode with Travis on AI in Medicine.
Connect with Ian McLachlan, BIO from the BAYOU producer.
Learn more about BIO from the BAYOU - the podcast.
Bio from the Bayou is a podcast that explores biotech innovation, business development, and healthcare outcomes in New Orleans & The Gulf South, connecting biotech companies, investors, and key opinion leaders to advance medicine, technology, and startup opportunities in the region.
English
United States
TRANSCRIPT 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
SEARCH PAST EPISODES
Search past episodes of BIO from the BAYOU: Build Your Biotech Network with Key Opinion Leaders and Investors.
OTHER EPISODES IN THIS PODCAST
Could family offices help biotech founders unlock new sources of capital in an increasingly challenging fundraising environment?
In this episode, host Elaine Hamm, PhD, sits down with Danielle Patterson, Executive Director of Family Office at ISS Market Intelligence, to explore the growing role of …
How do you turn a room full of strangers into meaningful professional relationships?
In the second installment of their three-part networking series, Elaine Hamm, PhD, is joined once again by special guest host James Zanewicz, JD, LLM, RTTP, to discuss what happens after you've done the preparation…
How can students start building a future in biotech before they even leave the lab?
In this episode, host Elaine Hamm, PhD, sits down with Haley Marcotte, Co-Managing Director of Nucleate New Orleans and a PhD student at Tulane University School of Medicine. Haley shares how discovering biotech as …
Have you ever left a conference with a stack of business cards… only to realize weeks later that you never followed up with the people you were most excited to meet?
In the final installment of their three-part networking series, Elaine Hamm, PhD, is joined once again by special guest host James Za…
How can biotech startup founders navigate the intersection of science, technology, and data to build truly durable companies?
In this episode, host Elaine Hamm, PhD, talks with Cain McClary, MD, Founder and Managing Partner of KdT Ventures, a seed-stage venture firm investing at the convergence of …
Disclaimer: The podcast and artwork embedded on this page are from Elaine Hamm, which is the property of its owner and not affiliated with or endorsed by Listen Notes, Inc.
EDIT
Thank you for helping to keep the podcast database up to date.
